<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04934072</url>
  </required_header>
  <id_info>
    <org_study_id>FKS518-002</org_study_id>
    <secondary_id>2020-004422-31</secondary_id>
    <nct_id>NCT04934072</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis</brief_title>
  <official_title>A Double-blind, Randomized, Multicenter, Multiple-dose, 2-arm, Parallel-group Study to Evaluate Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 - Proposed Biosimilar to Denosumab With Prolia® in Postmenopausal Women With Osteoporosis (LUMIADE-3 Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi SwissBioSim GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi SwissBioSim GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate equivalent efficacy of FKS518 to&#xD;
      US-licensed Prolia in women with postmenopausal osteoporosis (PMO).&#xD;
&#xD;
      Participants will be randomized at the beginning of the Double-blind Core Treatment Period&#xD;
      (Baseline to Week 52) to receive either FKS518 or US-licensed Prolia on Day 1, and then every&#xD;
      26 weeks for up to 52 weeks.&#xD;
&#xD;
      At the beginning of the Double-blind Transition Period (Week 52 to Week 78), participants who&#xD;
      received US-licensed Prolia will be re-randomized to either continue receiving US-licensed&#xD;
      Prolia every 26 weeks for up to 78 weeks, or switch to receive FKS518 every 26 weeks for up&#xD;
      to 78 weeks.&#xD;
&#xD;
      Participants who were randomized to receive FKS518 at the beginning of the Double-blind Core&#xD;
      Treatment Period will continue to receive this treatment during the Double-blind Transition&#xD;
      Period.&#xD;
&#xD;
      For Marketing Authorization Application (MAA) in the EU and European Economic Area (EEA)&#xD;
      only: The primary objective is to demonstrate equivalent efficacy and pharmacodynamics of the&#xD;
      proposed biosimilar denosumab FKS518 to US-Prolia in women with PMO.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2021</start_date>
  <completion_date type="Anticipated">March 20, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Change from Baseline in Lumbar Spine Bone Mineral Density (LS-BMD) by Dual Energy X-ray Absorptiometry (DXA) at Week 52</measure>
    <time_frame>Baseline (Screening) to Week 52</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Area Under the Effect Curve (AUEC) of Serum C-terminal Cross-Linking Telopeptide of Type 1 Collagen (CTX) at Week 26</measure>
    <time_frame>Baseline (Day 1) to Week 26</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage Change from Baseline in Serum C-terminal Cross-linking Telopeptide of Type 1 Collagen (CTX) at Week 52</measure>
    <time_frame>Baseline (Day 1) to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Change from Baseline in Bone Mineral Density (BMD) at Femoral Neck and Total Hip by Dual Energy X-ray Absorptiometry (DXA) at Week 52</measure>
    <time_frame>Baseline (Screening) to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage Change from Baseline in Serum Procollagen Type 1 N-terminal Propeptide (P1NP) at Week 52</measure>
    <time_frame>Baseline (Day 1) to Week 52</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experience a Treatment-emergent Adverse Event (TEAE)</measure>
    <time_frame>Day 1 to Week 78</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experience a Serious Adverse Event (SAE)</measure>
    <time_frame>Day 1 to Week 78</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experience a Treatment-emergent Adverse Event of Special Interest (AESI)</measure>
    <time_frame>Day 1 to Week 78</time_frame>
    <description>A Treatment-emergent Adverse Event of Special Interest (AESI) is defined as drug-related hypersensitivity/allergic reactions (Common Terminology Criteria for Adverse Events [CTCAE] Grade ≥3 or reported as serious adverse events [SAEs]) and adverse events (AEs) leading to investigational product (IP) discontinuation or study withdrawal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Experience an Injection Site Reaction (ISR)</measure>
    <time_frame>Day 1 to Week 56</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Antidrug Antibodies (ADAs)</measure>
    <time_frame>4 weeks prior to first drug administration to Week 78</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Antidrug Antibody (ADA) Titers</measure>
    <time_frame>4 weeks prior to first drug administration to Week 78</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Neutralizing Antibodies (NAb)</measure>
    <time_frame>4 weeks prior to first drug administration to Week 78</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">526</enrollment>
  <condition>Postmenopausal Osteoporosis</condition>
  <arm_group>
    <arm_group_label>FKS518</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>US-licensed Prolia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>FKS518</intervention_name>
    <description>Participants will receive FKS518 via subcutaneous injection, every 26 weeks.</description>
    <arm_group_label>FKS518</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>US-licensed Prolia</intervention_name>
    <description>Participants will receive US-licensed Prolia via subcutaneous injection, every 26 weeks.</description>
    <arm_group_label>US-licensed Prolia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Female ≥55 to ≤85 years of age, inclusive, at screening.&#xD;
&#xD;
          2. Have a body mass index (BMI) ≥18 to ≤32 kg/m^2.&#xD;
&#xD;
          3. Participant should have confirmed postmenopausal status, defined as age-related or&#xD;
             early/premature amenorrhea ≥12 consecutive months and increased follicle-stimulating&#xD;
             hormone (FSH) &gt;40 mIU/mL at screening; or surgical menopause (bilateral oophorectomy&#xD;
             with or without hysterectomy) ≥12 months prior to screening.&#xD;
&#xD;
          4. Absolute bone mineral density (BMD) consistent with T-score ≤-2.5 and ≥-4.0 at the&#xD;
             lumbar spine as measured by dual energy x-ray absorptiometry (DXA) as per central&#xD;
             assessment.&#xD;
&#xD;
          5. At least 2 vertebrae in the lumbar vertebrae 1 to lumbar vertebrae 4 (L1-L4) region&#xD;
             and at least 1 hip joint are evaluable by DXA.&#xD;
&#xD;
          6. Clinically acceptable physical examinations and laboratory tests and no history or&#xD;
             evidence of any clinically significant concomitant medical disorder that, in the&#xD;
             opinion of the Investigator, would pose a risk to participant safety or interfere with&#xD;
             study evaluations or procedures.&#xD;
&#xD;
          7. Written informed consent including accepting a separate Information Sheet containing&#xD;
             important information about COVID-19 and its general risks for participants&#xD;
             participating in the clinical trial.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Disease-related&#xD;
&#xD;
          1. History and/or presence of 1 severe or &gt;2 moderate vertebral fractures or hip fracture&#xD;
             confirmed by x-ray.&#xD;
&#xD;
          2. Presence of active healing fracture at screening.&#xD;
&#xD;
          3. History and/or presence of bone-related disorders, such as but not limited to Paget's&#xD;
             disease, osteomalacia, hyperparathyroidism (or parathyroid disorders), or renal&#xD;
             osteodystrophy.&#xD;
&#xD;
          4. Osteonecrosis of the jaw (ONJ) or risk factors for ONJ such as invasive dental&#xD;
             procedures (eg, tooth extraction, dental implants, or oral surgery in the past 6&#xD;
             months), poor oral hygiene, periodontal, and/or pre-existing dental disease as&#xD;
             assessed by the Investigator.&#xD;
&#xD;
          5. Evidence of hypocalcemia (albumin-adjusted serum calcium &lt;2.13 mmol/L or &lt;8.5 mg/dL)&#xD;
             or hypercalcemia (albumin-adjusted serum calcium &gt;2.6 mmol/L or &gt;10.5 mg/dL) as&#xD;
             assessed by the central laboratory at screening.&#xD;
&#xD;
          6. Vitamin D deficiency (25-hydroxy vitamin D levels &lt;12 ng/mL) as assessed by central&#xD;
             laboratory at screening (retest is allowed once).&#xD;
&#xD;
          7. Known intolerance to calcium or vitamin D supplements.&#xD;
&#xD;
             Other Medical Conditions&#xD;
&#xD;
          8. Known or suspected clinically relevant drug hypersensitivity to any components of the&#xD;
             study drug, comparable drugs, or to latex.&#xD;
&#xD;
          9. Renal impairment: creatinine clearance &lt;30 mL/min at screening or receiving dialysis.&#xD;
&#xD;
         10. Medical evidence of current or history of primary or secondary immunodeficiency.&#xD;
&#xD;
         11. Infection-related exclusions as further defined in the protocol.&#xD;
&#xD;
         12. Major surgical procedure within 8 weeks prior to the screening or scheduled during the&#xD;
             study.&#xD;
&#xD;
         13. Current or history of any malignancy, or myeloproliferative, or lymphoproliferative&#xD;
             disease within 5 years before screening.&#xD;
&#xD;
         14. History of clinically significant drug or alcohol abuse within the last year prior to&#xD;
             randomization.&#xD;
&#xD;
         15. Prior denosumab (Prolia, Xgeva, or proposed denosumab biosimilar) exposure.&#xD;
&#xD;
         16. Prior use of fluoride within the 5 years before inclusion in the study.&#xD;
&#xD;
         17. Any current or prior use of strontium ranelate.&#xD;
&#xD;
         18. Any current or prior use of intravenous bisphosphonates.&#xD;
&#xD;
         19. Current or prior use of teriparatide and other parathormone (PTH) analogues within 12&#xD;
             months before screening.&#xD;
&#xD;
         20. Current or prior use of systemic oral or transdermal estrogen or selective estrogen&#xD;
             receptor modulators or tibolone within 6 months before screening.&#xD;
&#xD;
         21. Current or prior use of calcitonin or cinacalcet within 3 months before screening or&#xD;
             any cathepsin K inhibitor (eg, odanacatib) within 18 months before screening.&#xD;
&#xD;
         22. Current or prior use of romosozumab or antisclerostin antibody.&#xD;
&#xD;
         23. Current or prior use of other osteoporotic agents used for the prevention or treatment&#xD;
             of osteoporosis.&#xD;
&#xD;
         24. Current use within 3 months before screening of any medication with known influence on&#xD;
             the skeletal system (eg, systemic corticosteroids, heparin, lithium, etc) with&#xD;
             exceptions described in the protocol.&#xD;
&#xD;
         25. Concomitant treatment with another biologic drug.&#xD;
&#xD;
         26. Have received a COVID-19 vaccine within 4 weeks before randomization or COVID-19&#xD;
             vaccination is ongoing at the time of screening.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Development Director</last_name>
    <email>medinfo_biosim@fresenius-kabi.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diagnostic Consultative Center Aleksandrovska</name>
      <address>
        <city>Sofia</city>
        <state>Sofia City</state>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diagnostic Consultative Center (DCC) 17 - Sofia</name>
      <address>
        <city>Sofia</city>
        <state>Sofia City</state>
        <zip>1505</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center N. I. Pirogov</name>
      <address>
        <city>Sofia</city>
        <state>Sofia City</state>
        <zip>1612</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Hipokrat 2000 OOD</name>
      <address>
        <city>Haskovo</city>
        <zip>6300</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Medconsult Pleven</name>
      <address>
        <city>Pleven</city>
        <zip>5800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Palmed University Multidisciplinary Hospital for Active Treatment</name>
      <address>
        <city>Plovdiv</city>
        <zip>4002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Multi-profile Hospital for Active Treatment - Plovdiv</name>
      <address>
        <city>Plovdiv</city>
        <zip>4003</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center - Teodora EOOD</name>
      <address>
        <city>Ruse</city>
        <zip>7012</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Multiprofile Hospital for Active Treatment Hadzhi Dimitar</name>
      <address>
        <city>Sliven</city>
        <zip>8800</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lyulin Hospital</name>
      <address>
        <city>Sofia</city>
        <zip>1336</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Diagnostic and Consultative Center Equita</name>
      <address>
        <city>Varna</city>
        <zip>9002</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Center Sanador M</name>
      <address>
        <city>Vidin</city>
        <zip>3703</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CCR Brno</name>
      <address>
        <city>Brno</city>
        <state>Jihormoravsky Kraj</state>
        <zip>602 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CCR Ostrava</name>
      <address>
        <city>Ostrava</city>
        <state>Severomoravsky Kraj</state>
        <zip>702 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Plus</name>
      <address>
        <city>Uherske Hradi?t?</city>
        <state>South Moravian</state>
        <zip>686 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>G-Centrum Olomouc s.r.o</name>
      <address>
        <city>Olomouc</city>
        <zip>772 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Artroscan</name>
      <address>
        <city>Ostrava-T?ebovice</city>
        <zip>722 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Plus</name>
      <address>
        <city>Uherske Hradi?t?</city>
        <zip>686 01</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Center for Clinical and Basic Research AS - Tallinn</name>
      <address>
        <city>Tallinn</city>
        <state>Harjumaa</state>
        <zip>10128</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sihtasutus Pohja-Eesti Regionaalhaigla</name>
      <address>
        <city>Tallinn</city>
        <state>Harjumaa</state>
        <zip>13419</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>KLV Arstikabinet</name>
      <address>
        <city>Parnu</city>
        <state>Parnumaa</state>
        <zip>80010</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tartu Ulikooli Kliinikum</name>
      <address>
        <city>Tartu</city>
        <state>Tartumaa</state>
        <zip>50406</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>KLV Arstikabinet</name>
      <address>
        <city>Parnu</city>
        <zip>80010</zip>
        <country>Estonia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Evex Hospitals - Caraps Medline</name>
      <address>
        <city>Tbilisi</city>
        <state>Borjomi</state>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Georgian-Dutch Hospital</name>
      <address>
        <city>Tbilisi</city>
        <state>Borjomi</state>
        <zip>0172</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hepatology Clinic Hepa</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Tbilisi Heart And Vascular Clinic Ltd</name>
      <address>
        <city>Tbilisi</city>
        <zip>0159</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jerarsi Clinic</name>
      <address>
        <city>Tbilisi</city>
        <zip>0167</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Raymann - Clinic of Raymann Doctors</name>
      <address>
        <city>Tbilisi</city>
        <zip>0186</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MedCity Ltd.</name>
      <address>
        <city>Tbilisi</city>
        <zip>186</zip>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar</name>
      <address>
        <city>Szeged</city>
        <state>Csongrad</state>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Csongrad-Csanad Megyei Dr. Bugyi Istvan Korhaz</name>
      <address>
        <city>Szentes</city>
        <state>Csongrad</state>
        <zip>6600</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar</name>
      <address>
        <city>Szeged</city>
        <state>Csongr</state>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szent Anna Magan N?gyogyaszati</name>
      <address>
        <city>Debrecen</city>
        <state>Hajdu-Bihar County</state>
        <zip>4024</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Markhot Ferenc Oktatokorhaz es Rendel?intezet</name>
      <address>
        <city>Eger</city>
        <state>Heves</state>
        <zip>3300</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pest Megyei Flor Ferenc Korhaz</name>
      <address>
        <city>Kistarcsa</city>
        <state>Pest</state>
        <zip>2143</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Obudai Egeszsegugyi Centrum</name>
      <address>
        <city>Zalaegerszeg</city>
        <state>Zala</state>
        <zip>8900</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Drug Research Center Balatonfured</name>
      <address>
        <city>Balatonfured</city>
        <zip>8230</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Revita Rendel?</name>
      <address>
        <city>Budapest</city>
        <zip>1027</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinexpert Gyogycentrum</name>
      <address>
        <city>Budapest</city>
        <zip>1033</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Obudai Egeszsegugyi Centrum</name>
      <address>
        <city>Budapest</city>
        <zip>1036</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem - I. sz. Belgyogyaszati Klinika</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Kozpont Kenezy Gyula Campus</name>
      <address>
        <city>Debrecen</city>
        <zip>4031</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Markhot Ferenc Oktatokorhaz es Rendel?intezet</name>
      <address>
        <city>Eger</city>
        <zip>3300</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kalocsai Szent Kereszt Korhaz</name>
      <address>
        <city>Kalocsa</city>
        <zip>6300</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CMed Rehabilitacios es Diagnosztikai Kozpont / Saldinvest Kft.</name>
      <address>
        <city>Szekesfehervar</city>
        <zip>8000</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Vital Medical Center - Reumatologia</name>
      <address>
        <city>Veszprem</city>
        <zip>8200</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ambulatorium Sp z o.o. - Elbl?g</name>
      <address>
        <city>Elbl?g</city>
        <state>?u?awy</state>
        <zip>82-300</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FutureMeds</name>
      <address>
        <city>Wroc?aw</city>
        <state>Dolnoslaskie</state>
        <zip>50-088</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wromedica Centrum Zdrowia</name>
      <address>
        <city>Wroc?aw</city>
        <state>Dolnoslaskie</state>
        <zip>51-685</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Oporow</name>
      <address>
        <city>Wroc?aw</city>
        <state>Dolnoslaskie</state>
        <zip>52-416</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nasz Lekarz Przychodnie Medyczne</name>
      <address>
        <city>Toru?</city>
        <state>Kujawsko-Pomorskie</state>
        <zip>87-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne All-Med</name>
      <address>
        <city>Krakow</city>
        <state>Malopolskie</state>
        <zip>30-033</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pratia MCM Krakow</name>
      <address>
        <city>Krakow</city>
        <state>Malopolskie</state>
        <zip>30-510</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>RCMed Oddzial Sochaczew</name>
      <address>
        <city>Sochaczew</city>
        <state>Mazowieckie</state>
        <zip>96-500</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne AMED - Warszawa Targowek</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>01-518</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Twoja Przychodnia Szczeci?skie Centrum Medyczne</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>02-777</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rheuma Medicus - Specjalistyczne Centrum Reumatologii i Osteoporozy</name>
      <address>
        <city>Warszawa-Ochota</city>
        <state>Mazowieckie</state>
        <zip>02-118</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medycyna Kliniczna</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>00-874</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SOMED CR - ?od?</name>
      <address>
        <city>Warszawa</city>
        <state>Mazowieckie</state>
        <zip>04-730</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ZDROWIE Osteo-Medic s.c. L. I A. Racewicz, A. i J. Supronik</name>
      <address>
        <city>Bia?ystok</city>
        <state>Podlaskie</state>
        <zip>15-351</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ClinicMed</name>
      <address>
        <city>Bia?ystok</city>
        <state>Podlaskie</state>
        <zip>15-879</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Nasz Lekarz O?rodek Bada? Klinicznych - Bydgoszcz</name>
      <address>
        <city>Bydgoszcz</city>
        <state>Pomorskie</state>
        <zip>85-065</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Szpital Uniwersytecki nr 2 im. dr. Jana Biziela w Bydgoszczy</name>
      <address>
        <city>Bydgoszcz</city>
        <state>Pomorskie</state>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia - Gdynia</name>
      <address>
        <city>Gdynia</city>
        <state>Pomorskie</state>
        <zip>81-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Pratia - Gdynia</name>
      <address>
        <city>Gdynia</city>
        <state>Pomorskie</state>
        <zip>81-340</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gabinet diagnostyki i leczenia osteoporozy</name>
      <address>
        <city>Gliwice</city>
        <state>Slaskie</state>
        <zip>44-122</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Kliniczno Badawcze J Brzezicki B Gornikiewicz Brzezicka Lekarze Spo?ka Partnerska</name>
      <address>
        <city>Elbl?g</city>
        <state>Warminsko-Mazurskie</state>
        <zip>82-300</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne Solumed</name>
      <address>
        <city>Pozna?</city>
        <state>Wielkopolskie</state>
        <zip>60-529</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Bada? Klinicznych</name>
      <address>
        <city>Poznan</city>
        <state>Wielkopolskie</state>
        <zip>60-773</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centrum Medyczne All-Med</name>
      <address>
        <city>Krakow</city>
        <zip>31-023</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>SOMED CR - ?od?</name>
      <address>
        <city>Lodz</city>
        <zip>90-368</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Twoja Przychodnia - Centrum Medyczne Nowa Sol</name>
      <address>
        <city>Nowa Sol</city>
        <zip>67-100</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Twoja Przychodnia Szczeci?skie Centrum Medyczne</name>
      <address>
        <city>Szczecin</city>
        <zip>71-434</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Zespo? Opieki Zdrowotnej w Tomaszow Lubelski</name>
      <address>
        <city>Tomaszow Lubelski</city>
        <zip>22-600</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinika Reuma Park sp. z o.o. sp.k - Centrum Medyczne Reuma Park</name>
      <address>
        <city>Warszawa</city>
        <zip>02-691</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>Czechia</country>
    <country>Estonia</country>
    <country>Georgia</country>
    <country>Hungary</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 3, 2021</study_first_submitted>
  <study_first_submitted_qc>June 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 22, 2021</study_first_posted>
  <last_update_submitted>October 13, 2021</last_update_submitted>
  <last_update_submitted_qc>October 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postmenopausal Osteoporosis</keyword>
  <keyword>FKS518</keyword>
  <keyword>Denosumab</keyword>
  <keyword>US-licensed Prolia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Osteoporosis, Postmenopausal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Denosumab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

